Paige Gosling Wickner, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Hypersensitivity | 19 | 2023 | 883 | 3.090 |
Why?
|
Anaphylaxis | 9 | 2021 | 746 | 1.510 |
Why?
|
Hypersensitivity | 8 | 2023 | 1102 | 1.340 |
Why?
|
beta-Lactams | 5 | 2023 | 160 | 1.030 |
Why?
|
Desensitization, Immunologic | 4 | 2021 | 483 | 0.770 |
Why?
|
Progestins | 2 | 2020 | 306 | 0.640 |
Why?
|
Checklist | 2 | 2020 | 830 | 0.550 |
Why?
|
Skin Tests | 7 | 2023 | 612 | 0.490 |
Why?
|
Medical Records | 1 | 2019 | 1413 | 0.480 |
Why?
|
Hypersensitivity, Immediate | 1 | 2016 | 337 | 0.450 |
Why?
|
Thrombocytopenia | 1 | 2021 | 1175 | 0.440 |
Why?
|
Electronic Health Records | 6 | 2022 | 4463 | 0.420 |
Why?
|
Health Personnel | 3 | 2021 | 3216 | 0.370 |
Why?
|
Blood Platelets | 1 | 2021 | 2508 | 0.370 |
Why?
|
Occupational Exposure | 1 | 2020 | 1796 | 0.350 |
Why?
|
Vaccines, Synthetic | 2 | 2021 | 634 | 0.310 |
Why?
|
Communication | 3 | 2023 | 3749 | 0.310 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3132 | 0.310 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3239 | 0.310 |
Why?
|
Anti-Bacterial Agents | 6 | 2019 | 7179 | 0.260 |
Why?
|
Medicine, African Traditional | 1 | 2004 | 29 | 0.250 |
Why?
|
Documentation | 4 | 2022 | 869 | 0.230 |
Why?
|
Midwifery | 1 | 2004 | 132 | 0.220 |
Why?
|
Food Hypersensitivity | 2 | 2022 | 622 | 0.210 |
Why?
|
Asthma, Aspirin-Induced | 2 | 2016 | 182 | 0.200 |
Why?
|
Penicillins | 3 | 2023 | 380 | 0.200 |
Why?
|
Decision Support Systems, Clinical | 3 | 2019 | 1162 | 0.180 |
Why?
|
Medical Order Entry Systems | 2 | 2015 | 544 | 0.170 |
Why?
|
Organoplatinum Compounds | 1 | 2021 | 408 | 0.170 |
Why?
|
Toilet Facilities | 1 | 2019 | 26 | 0.170 |
Why?
|
Delayed Diagnosis | 2 | 2020 | 441 | 0.170 |
Why?
|
Vaccination | 5 | 2021 | 3278 | 0.170 |
Why?
|
Current Procedural Terminology | 1 | 2019 | 92 | 0.170 |
Why?
|
Academic Medical Centers | 2 | 2020 | 2759 | 0.170 |
Why?
|
Humans | 56 | 2024 | 744220 | 0.170 |
Why?
|
Personnel, Hospital | 1 | 2021 | 283 | 0.170 |
Why?
|
Drug Eruptions | 1 | 2021 | 297 | 0.160 |
Why?
|
Platelet Count | 1 | 2021 | 781 | 0.160 |
Why?
|
Urticaria | 1 | 2019 | 150 | 0.160 |
Why?
|
Angioedema | 1 | 2019 | 187 | 0.160 |
Why?
|
Nausea | 1 | 2021 | 668 | 0.160 |
Why?
|
Boston | 3 | 2021 | 9311 | 0.160 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 252 | 0.150 |
Why?
|
Delivery, Obstetric | 1 | 2004 | 906 | 0.150 |
Why?
|
Angioedemas, Hereditary | 1 | 2018 | 91 | 0.150 |
Why?
|
Hospitals, General | 1 | 2021 | 749 | 0.140 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 2279 | 0.140 |
Why?
|
Adverse Drug Reaction Reporting Systems | 2 | 2022 | 469 | 0.140 |
Why?
|
Radiology | 2 | 2022 | 2099 | 0.140 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2019 | 397 | 0.140 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2020 | 720 | 0.130 |
Why?
|
Insurance Claim Review | 1 | 2019 | 720 | 0.130 |
Why?
|
Hypotension | 1 | 2021 | 880 | 0.130 |
Why?
|
Stevens-Johnson Syndrome | 2 | 2016 | 280 | 0.120 |
Why?
|
Clinical Alarms | 1 | 2015 | 51 | 0.120 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2016 | 371 | 0.120 |
Why?
|
International Classification of Diseases | 1 | 2019 | 867 | 0.120 |
Why?
|
Disclosure | 1 | 2020 | 736 | 0.120 |
Why?
|
Inpatients | 4 | 2019 | 2518 | 0.120 |
Why?
|
Diffusion of Innovation | 1 | 2019 | 725 | 0.120 |
Why?
|
Databases as Topic | 1 | 2015 | 475 | 0.110 |
Why?
|
Patients | 1 | 2020 | 900 | 0.110 |
Why?
|
Cost Savings | 1 | 2019 | 926 | 0.110 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2021 | 941 | 0.110 |
Why?
|
Physicians | 2 | 2022 | 4564 | 0.110 |
Why?
|
Practice Guidelines as Topic | 4 | 2019 | 7281 | 0.110 |
Why?
|
Hypersensitivity, Delayed | 1 | 2014 | 485 | 0.110 |
Why?
|
Patient Satisfaction | 3 | 2022 | 3395 | 0.110 |
Why?
|
Vancomycin | 1 | 2016 | 501 | 0.110 |
Why?
|
Burnout, Professional | 1 | 2021 | 694 | 0.110 |
Why?
|
Pandemics | 6 | 2023 | 8387 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.100 |
Why?
|
Occupational Diseases | 1 | 2020 | 1472 | 0.100 |
Why?
|
Nasal Polyps | 1 | 2016 | 360 | 0.100 |
Why?
|
Cross Infection | 1 | 2020 | 1416 | 0.090 |
Why?
|
Drug Utilization | 1 | 2017 | 1183 | 0.090 |
Why?
|
Respiration Disorders | 1 | 2014 | 371 | 0.090 |
Why?
|
Respiratory Sounds | 2 | 2014 | 696 | 0.090 |
Why?
|
Incidence | 4 | 2021 | 20945 | 0.090 |
Why?
|
Consensus | 1 | 2018 | 2958 | 0.090 |
Why?
|
Delivery of Health Care | 4 | 2022 | 5319 | 0.090 |
Why?
|
Colonic Neoplasms | 1 | 2021 | 2538 | 0.080 |
Why?
|
Hemorrhage | 1 | 2021 | 3461 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2458 | 0.080 |
Why?
|
Family | 1 | 2020 | 3148 | 0.080 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2011 | 183 | 0.080 |
Why?
|
Thalidomide | 1 | 2014 | 890 | 0.080 |
Why?
|
Asthma | 2 | 2021 | 6011 | 0.080 |
Why?
|
Terminology as Topic | 1 | 2015 | 1548 | 0.080 |
Why?
|
Algorithms | 2 | 2020 | 13885 | 0.080 |
Why?
|
Adult | 11 | 2021 | 214035 | 0.080 |
Why?
|
Female | 18 | 2022 | 380197 | 0.080 |
Why?
|
Allergens | 3 | 2022 | 1320 | 0.080 |
Why?
|
Ethanol | 1 | 2014 | 1342 | 0.070 |
Why?
|
Cephalosporins | 2 | 2019 | 204 | 0.070 |
Why?
|
RNA, Messenger | 4 | 2021 | 13036 | 0.070 |
Why?
|
Middle Aged | 12 | 2021 | 213367 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5442 | 0.070 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13668 | 0.070 |
Why?
|
Gender Identity | 2 | 2021 | 688 | 0.070 |
Why?
|
Male | 16 | 2021 | 350027 | 0.070 |
Why?
|
Retrospective Studies | 7 | 2024 | 77426 | 0.070 |
Why?
|
Camphor | 1 | 2004 | 9 | 0.060 |
Why?
|
Nicaragua | 1 | 2004 | 27 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2014 | 1582 | 0.060 |
Why?
|
Prospective Studies | 4 | 2021 | 53280 | 0.060 |
Why?
|
Cohort Studies | 4 | 2021 | 40559 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 2872 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 7730 | 0.060 |
Why?
|
Umbilical Cord | 1 | 2004 | 180 | 0.060 |
Why?
|
Amoxicillin | 1 | 2023 | 170 | 0.050 |
Why?
|
Excipients | 1 | 2021 | 96 | 0.050 |
Why?
|
Anemia | 1 | 2011 | 1504 | 0.050 |
Why?
|
Massachusetts | 3 | 2020 | 8663 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 11732 | 0.040 |
Why?
|
Opioid-Related Disorders | 1 | 2015 | 2065 | 0.040 |
Why?
|
Ambulatory Care | 2 | 2022 | 2708 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9275 | 0.040 |
Why?
|
United States | 7 | 2020 | 69867 | 0.040 |
Why?
|
Danazol | 1 | 2018 | 42 | 0.040 |
Why?
|
User-Computer Interface | 2 | 2015 | 1426 | 0.040 |
Why?
|
Faculty | 1 | 2021 | 386 | 0.040 |
Why?
|
Spirometry | 1 | 2021 | 864 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2021 | 25043 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2020 | 840 | 0.040 |
Why?
|
Hospitals, Urban | 1 | 2019 | 499 | 0.040 |
Why?
|
Republic of Korea | 1 | 2018 | 539 | 0.030 |
Why?
|
Problem Solving | 1 | 2019 | 440 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5180 | 0.030 |
Why?
|
Expert Testimony | 1 | 2018 | 356 | 0.030 |
Why?
|
Young Adult | 3 | 2019 | 56436 | 0.030 |
Why?
|
Systematized Nomenclature of Medicine | 1 | 2015 | 36 | 0.030 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2016 | 85 | 0.030 |
Why?
|
Nephritis, Interstitial | 1 | 2016 | 156 | 0.030 |
Why?
|
Critical Pathways | 1 | 2019 | 476 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2018 | 594 | 0.030 |
Why?
|
Radiology Department, Hospital | 1 | 2019 | 412 | 0.030 |
Why?
|
Hospitalization | 3 | 2020 | 10262 | 0.030 |
Why?
|
Policy | 1 | 2018 | 508 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.030 |
Why?
|
Vocabulary, Controlled | 1 | 2015 | 170 | 0.030 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2015 | 203 | 0.030 |
Why?
|
Leukotriene E4 | 1 | 2014 | 79 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2018 | 764 | 0.030 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2014 | 80 | 0.030 |
Why?
|
Quality Improvement | 2 | 2019 | 3746 | 0.030 |
Why?
|
Aged | 7 | 2020 | 163253 | 0.030 |
Why?
|
Utilization Review | 1 | 2015 | 392 | 0.030 |
Why?
|
Standard of Care | 1 | 2017 | 564 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1583 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 950 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3527 | 0.030 |
Why?
|
Infection Control | 1 | 2020 | 964 | 0.030 |
Why?
|
Exanthema | 1 | 2017 | 501 | 0.030 |
Why?
|
International Cooperation | 1 | 2018 | 1421 | 0.030 |
Why?
|
Emotions | 1 | 2023 | 2659 | 0.020 |
Why?
|
Drug Interactions | 1 | 2015 | 1458 | 0.020 |
Why?
|
Self Report | 1 | 2021 | 3558 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2016 | 1463 | 0.020 |
Why?
|
Outpatients | 1 | 2017 | 1486 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5076 | 0.020 |
Why?
|
Medication Errors | 1 | 2015 | 797 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1169 | 0.020 |
Why?
|
Adolescent | 1 | 2016 | 85759 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10396 | 0.020 |
Why?
|
Natural Language Processing | 1 | 2015 | 1040 | 0.020 |
Why?
|
Pregnancy | 2 | 2011 | 29142 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1955 | 0.020 |
Why?
|
Dyspnea | 1 | 2014 | 1303 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8321 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3952 | 0.020 |
Why?
|
Computational Biology | 1 | 2016 | 3523 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21752 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19907 | 0.010 |
Why?
|
Risk Factors | 2 | 2021 | 72280 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2017 | 57768 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15226 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40063 | 0.010 |
Why?
|
Infant | 1 | 2011 | 35129 | 0.010 |
Why?
|
Child, Preschool | 1 | 2011 | 40992 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2014 | 63119 | 0.000 |
Why?
|
Child | 1 | 2011 | 77679 | 0.000 |
Why?
|